No Data
Alphabet Inc. (GOOGL)'s Isomorphic Labs to Begin Clinical Trials for AI-Designed Drugs, Targeting Faster Drug Discovery
AI Trade Gets a Big Boost From the Stargate Project
Cantor Fitzgerald Adjusts Price Target on Alphabet to $210 From $215, Keeps Neutral Rating
Tesla Sits at 'Epicenter' of a 'Cambrian Explosion' in New Tech. Sounds Exciting. -- Barrons.com
Google has added an investment of 1 billion dollars to its competitor Anthropic, OpenAI.
Previously, Google had pledged to invest an additional 2 billion USD in Anthropic. Reports indicate that Anthropic will also receive an additional 2 billion USD in Silicon Valley venture capital, and this Trade is expected to increase its valuation to 60 billion USD, three times the previous valuation.
Google Parent-Owned Startup To Launch AI-Designed Drug Trials By Year-End, Partnering With Eli Lilly And Novartis To Tackle Major Diseases
loading...